US Broker Ratings

Centene Corporation (CNC) Investor Outlook: Assessing a 38.54% Potential Upside in the Healthcare Sector

Centene Corporation (NYSE: CNC) stands as a formidable name within the U.S. healthcare sector, operating as a key player in the healthcare plans industry. With a..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: A Closer Look at Its 20.97% Potential Upside

GE HealthCare Technologies Inc. (NYSE: GEHC), a prominent player in the healthcare sector, is capturing the attention of individual investors with its robust market presence and..

The Cigna Group (CI) Investor Outlook: Analyzing a Promising 18.25% Upside Potential

The Cigna Group (NYSE: CI), a stalwart in the healthcare sector, continues to capture the attention of investors with its robust market presence and promising growth..

HealthEquity, Inc. (HQY) Stock Analysis: 16% Upside Potential and Strong Buy Ratings Capture Investor Attention

HealthEquity, Inc. (NASDAQ: HQY), a prominent player in the health information services sector, is capturing the attention of investors with a compelling potential upside of 16.18%...

Amgen Inc. (AMGN) Stock Analysis: A Strong Return on Equity and Growth Potential

Amgen Inc. (NASDAQ: AMGN), a stalwart in the healthcare sector, continues to capture investor interest with its robust product lineup and impressive financial metrics. The company,..

AstraZeneca PLC (AZN): Investor Outlook Highlights 13.12% Potential Upside and Strong Buy Ratings

AstraZeneca PLC (AZN), a titan in the global healthcare sector, continues to capture investor attention with its robust pipeline and strategic collaborations aimed at revolutionizing drug..

Universal Health Services, Inc. (UHS) Stock Analysis: Evaluating a 31.72% Potential Upside

Universal Health Services, Inc. (NYSE: UHS), a formidable player in the healthcare sector, presents a compelling opportunity for investors with a potential upside of 31.72% as..

Novo Nordisk A/S (NVO): Valuation Insights Reveal Potential Upside for Investors

Novo Nordisk A/S (NYSE: NVO), a titan in the healthcare sector, is capturing investor attention with its substantial market cap of $356.66 billion and a promising..

BeOne Medicines Ltd. (ONC) Stock Analysis: A Promising 23.12% Upside Potential in the Biotech Sector

BeOne Medicines Ltd. (ONC), a Switzerland-based biotechnology company, is making significant waves in the healthcare sector with its innovative approach to oncology. With a market capitalization..

Gilead Sciences, Inc. (GILD) Stock Analysis: Evaluating a Robust Pipeline and 5.47% Potential Upside

Gilead Sciences, Inc. (NASDAQ: GILD), a major player in the healthcare sector, particularly in the field of drug manufacturing, continues to be a focal point for..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Analyst Ratings Suggest a 38.82% Upside

Thermo Fisher Scientific Inc (NYSE: TMO), a stalwart in the healthcare sector, operates within the diagnostics and research industry, providing a comprehensive array of life sciences..

Roivant Sciences Ltd. (ROIV) Investor Outlook: Uncovering a 47.97% Potential Upside

Roivant Sciences Ltd. (NASDAQ: ROIV) stands out in the biotechnology sector with its promising portfolio of clinical-stage biopharmaceutical products. Founded in 2014 and headquartered in London,..

Zimmer Biomet Holdings (ZBH): Investor Outlook Reveals 17.77% Potential Upside

As investors continue to navigate the unpredictable waters of the healthcare sector, Zimmer Biomet Holdings, Inc. (NYSE: ZBH) stands out as a steadfast player in the..

Alcon Inc. (ALC) Stock Analysis: Eyeing a 22.73% Upside with Strong Buy Ratings

Alcon Inc. (ALC), a leading player in the healthcare sector, specifically in medical instruments and supplies, is capturing investor attention with its promising growth potential and..

Avantor, Inc. (AVTR) Stock Analysis: Exploring a 31% Potential Upside for Investors

Avantor, Inc. (NYSE: AVTR), a critical player in the healthcare sector, operates within the medical instruments and supplies industry. With a market capitalization of $8.91 billion,..

DaVita Inc. (DVA) Stock Analysis: Exploring a 19.69% Upside Potential

DaVita Inc. (NYSE: DVA), a leading player in the U.S. medical care facilities industry, has garnered attention from investors with a potential upside of nearly 20%..

Walgreens Boots Alliance, Inc. (WBA): Investor Outlook Highlights Robust Dividend Yield Amidst Challenging Metrics

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), a stalwart in the healthcare sector, operates a vast network of retail pharmacies and healthcare services across the United States..

Humana Inc. (HUM) Stock Analysis: Exploring a Potential 26.89% Upside for Investors

Humana Inc. (HUM), a major player in the healthcare plans industry, presents an intriguing opportunity for investors seeking exposure to the dynamic healthcare sector. With a..

Quest Diagnostics (DGX) Stock Analysis: Insights on Growth and Investor Ratings in the Healthcare Sector

Quest Diagnostics Incorporated (NYSE: DGX), a stalwart in the diagnostics and research industry, has been capturing the attention of investors with its steady growth and robust..

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a Potential 34.85% Upside for Investors

United Therapeutics Corporation (NASDAQ: UTHR), a key player in the biotechnology sector, has captured investor attention with its promising growth trajectory and robust pipeline. Specializing in..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds